top of page
AEYE Health Logo

1 minute
AI diabetic eye exam

 Screen Patients Anywhere with Our FDA-Cleared Solution:
Instant Diagnosis, Care Gap Closure, and Maximized Reimbursement with a Dedicated CPT Code

sphere.png
image.png
Optomed-Mamta-seeingresults-tulos-lights_patient view (1).png

AEYE Diagnostic Screening Solutions

sphere_light.png
contact image.png
The first FDA-cleared
portable AI Screening Solution 
 Experience on-the-spot detection of diabetic retinopathy with our portable handheld camera. This solution enables you to screen patients anywhere—whether at home or in the clinic.
1-Minute FDA-Cleared  AI Screening
with a Robotic Camera
Achieve on-the-spot detection of diabetic retinopathy with our robotic tabletop camera, designed for superior ease of use.
sphere_light.png
Untitled design (27)_edited.png

 The Only Practical Solution

 The Ultimate Solution for Diabetic Retinopathy Screening 

Our advanced technology enables you to screen patients for diabetic retinopathy in just one minute.
The process is painless, requires no dilation, and delivers instant, accurate results. With AEYE-DS, you can elevate patient care, streamline your practice, and achieve superior outcomes.

Key Features

icon3_edited.png

1-Minute Screening:

Conducted by clinic staff members, delivering instant diagnosis using either a portable or tabletop camera. No physician interpretation needed.​​

icon2_edited.png

Dedicated CPT Code 92229

National average reimbursement of $50 per screening.

icon1_edited.png

Care-Gap Closure and Quality Boost

Close the diabetic eye exam care gap and improve HEDIS scores, star ratings, and benefit from merit-based incentive payment systems.

  • How does AEYE-DS Work?
    The solution operates seamlessly with either a portable handheld camera or a robotic desktop camera in just three simple steps. First, a single image per eye is captured using one of the designated cameras. Next, the images are uploaded to the AEYE-DS system, which instantly generates a diagnosis along with a detailed diagnostic report, simplifying record-keeping and facilitating claims. The solution does not require any physician overseas.
  • What is the output of the solution?
    The solution provides one of two diagnoses: either the patient is negative for more than mild diabetic retinopathy (referable DR) and should be retested in 12 months, or the patient is positive, in which case they should be referred to a specialist for follow-up and treatment.
  • Who can operate the solution?
    No physician interpretation is needed. The solution can be operated by any healthcare professional, including medical assistants, technicians, or nurses, with minimal training required.
  • What is the payment model?
    The solution is offered through a subscription model, allowing for an unlimited number of monthly exams. Camera lease is included as part of a bundle, eliminating the need for equipment purchase.

Frequently Asked Questions

 We believe AEYE-DS is the best screening solution out there,
but don’t just take our word for it.
Hear from our satisfied users.

Sean Ianchulev MD, MPH, CEO at Eyenovia. Professor of Ophthalmology at UCSF & Mt. Sinai Smiling Photo

The time has finally come for autonomous screening technology to exceed the efficacy of the human expert. The implications are that it can be practical for deployment on the front lines of population health – the primary care offices, where over 99% imageability and single image diagnostic acquisition are tantamount to market success

Sean Ianchulev

MD, MPH, CEO at Eyenovia. Professor of Ophthalmology at UCSF & Mt. Sinai

Ready to get started? Still have questions?

Thanks for submitting!

sphere.png
contact image.png
AEYE Health Logo

Our Products

Our Solutions

Resources

Company

New York

1501 Broadway (12th floor), New York, NY 10036, USA 

​

+1 866 262 7343

Tel Aviv

© 2023 AEYE Health. All rights reserved

  • LinkedIn
  • Facebook
  • Twitter

28 HaArba'a street, South Building, 30th floor. 6473925

bottom of page